Your Followed Topics

Top 2 norway, norway News Today

#1
DoorDash unites brands in FIFA World Cup campaign
#1 out of 2
sports1d ago

DoorDash unites brands in FIFA World Cup campaign

https://marketingreport.one/creation/doordash-unites-brands-in-fifa-world-cup-campaign.html
Marketingreport.one
  • DoorDash, Deliveroo and Wolt launch a joint global FIFA World Cup 2026 campaign, Deliver Us To Fútbol.
  • The campaign runs across TV, VOD, outdoor, digital, audio and social, with local activations in multiple markets.
  • DoorDash is Official On-Demand Delivery Supporter and Official Restaurant Reservations Platform Supporter of the World Cup.
  • Campaign highlights fan rituals and matchday experiences, portraying delivery services as a help system for fans.
  • Celebrities Ricardo Kaká, Alex Morgan and Khaby Lame appear in the campaign.
  • The initiative includes Summer of DashPass relaunch and partnerships with FIFA sponsors in the US and Europe.
  • Brands plan watch parties, fan festivals and promotional events during the tournament.
  • Gina Igwe of DoorDash calls the World Cup campaign a defining moment to unite the brands across cultures.
  • Alex Morgan emphasizes connection and support for fans through DashPass during the World Cup.
  • The campaign extends beyond advertising with in-market watch parties and events.
Vote 0
0
#2
‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy
#2 out of 2
health19h ago

‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy

https://www.theguardian.com/society/2026/may/29/breast-cancer-chemotherapy-genomic-test-case-study
Theguardian.com
  • The Optima trial found some breast cancer patients could safely skip chemotherapy based on a genomic test.
  • Five-year cancer-free survival was 93.7% for those who skipped chemo, versus 94.9% with chemotherapy.
  • Karen Bonham from Wales participated and avoided chemotherapy after the test results in 2017.
  • The Prosigna test analyzes 50 genes to determine molecular subtype and recurrence risk.
  • Experts hail the findings as game-changing for personalizing breast cancer care.
  • Results were presented at the American Society of Clinical Oncology meeting in Chicago.
  • Bonham reports nine years post-diagnosis with no signs of disease.
  • The trial recruited 4,429 patients across multiple countries, including the UK, Norway, and Sweden.
  • Some patients still need chemotherapy; decisions depend on individual risk.
Vote 0
0

Explore Your Interests

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement